Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa.
about
Bone marrow suppression and severe anaemia associated with persistent Plasmodium falciparum infection in African children with microscopically undetectable parasitaemiaRational approaches to improving selectivity in drug designMitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsCharacterization of Plasmodium falciparum co-chaperone p23: its intrinsic chaperone activity and interaction with Hsp90Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor libraryWorld Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.CD4 T-cell expression of IFN-γ and IL-17 in pediatric malarial anemia.Progressive increase in point mutations associates chloroquine resistance: Even after withdrawal of chloroquine use in IndiaPatterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data.Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasitesUse of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparumUsing evidence to change antimalarial drug policy in Kenya.Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions.Effectiveness of a community intervention on malaria in rural Tanzania - a randomised controlled trial.Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.Increasing antimalarial drug resistance in Uganda and revision of the national drug policy.Evaluation of chloroquine as a potent anti-malarial drug: issues of public health policy and healthcare delivery in post-war Liberia.Quality of malaria case management in Malawi: results from a nationally representative health facility surveyFactors contributing to anemia after uncomplicated falciparum malaria.Taking stock: provider prescribing practices in the presence and absence of ACT stock.Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.History, dynamics, and public health importance of malaria parasite resistance.Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective.Impact of Malaria Control on Mortality and Anemia among Tanzanian Children Less than Five Years of Age, 1999-2010Maternal malaria and perinatal HIV transmission, western Kenya.Analyzing a Potential Drug Target N-Myristoyltransferase of Plasmodium falciparum Through In Silico ApproachesChemotherapy of drug-resistant malariaThe Blantyre Integrated Malaria Initiative: a model for effective malaria controlReturn of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasitesThe changing limits and incidence of malaria in Africa: 1939-2009.Antimalarial drug therapy: the role of parasite biology and drug resistance.In-vivo parasitological response to sulfadoxine-pyrimethamine in pregnant women in southern MalawiSelf-treatment of malaria in a rural area of western Kenya.Clinical signs for the recognition of children with moderate or severe anaemia in western KenyaMalaria research and its influence on anti-malarial drug policy in Malawi: a case study.Scaling up impact of malaria control programmes: a tale of events in Sub-Saharan Africa and People's Republic of China.Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in MaliImpact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study.Prevalence of malaria, prevention measures, and main clinical features in febrile children admitted to the Franceville Regional Hospital, Gabon.
P2860
Q24812638-6EAE848E-912C-44AE-A8F5-AE9EFEE9D9BFQ26865357-30F03CD3-EC1E-4FBA-B38D-7E9A1C688F97Q27000750-DF0521C6-C3E4-4D89-B5ED-EB68638BF8C9Q27974073-4E57074B-B431-42F4-8B52-6C8AB0FA8C72Q28534763-D2110E8C-13F3-4E69-ADFA-FD95BEEBA79DQ30483555-89E24E60-2C8D-432A-9C4F-4139C106E1B5Q33584826-3A5E2A09-DDA3-4BF8-AD6A-AA4A45F82B82Q33889755-C0447FF0-C5D4-46B9-852A-B44E5AEBC865Q33893267-B549FEE7-60AD-431B-AB2B-FA9DB144142CQ33908753-982E6026-D5E8-45F4-82A6-162571DC97D2Q33979170-619B10A0-EDAE-42E3-BFC5-99788EE5FE40Q33981071-660DDDBB-F3FF-40D0-B3B2-8FE54116B65DQ34109430-BE5F6504-3970-4A9F-A67E-D5CD7CC08410Q34488950-1F39F9C8-985C-40DB-BF56-F2FCD6C99877Q34643183-A6DA6E55-AF7A-425F-BFAC-B0FF065D5A28Q34743292-AE9C799F-14AC-4C83-888E-D6B419496DE2Q35013414-ADDBFB89-6794-49AB-B402-410FB9035BE2Q35056857-8525B2E5-4C0C-4930-B740-458CAAB0E303Q35106591-858FD4AF-F62E-4A93-B9EB-3DD769C68468Q35112361-42975225-E409-4742-85A4-57F289BC7068Q35185058-08C62299-ED35-453E-8F3C-2EBEE77F548FQ35205935-07DFFE57-51C7-46B1-B958-21BB56CC000AQ35545447-AAD12456-19F0-4811-85F3-60CCF313BF2BQ35755266-2A0D31D9-37DB-4EE4-BCC6-D163DF13D558Q35832081-F5C9C7ED-9205-47DF-A0F4-A7875B4A7948Q35880187-68294314-389D-4690-8C50-A2781C780F5BQ35890499-21DAF87B-2C0F-4A92-BC5F-1A062DB636ACQ35891386-18DA8714-E89F-44AC-B247-9261D6DCDA82Q35937366-2FF3DF7A-7772-4F75-9FEB-09FEEEEEF5C5Q36050791-54BE783D-E96B-4F1F-94E4-A2FDDE998298Q36463337-E9603887-E8C7-4379-B141-B1236622EE27Q36652599-A5BA99E0-8CCB-4A31-9C4F-AAB427C20C2AQ36736817-FFFF3344-161D-4F80-B70F-A4FA84D79745Q36794819-F9E8293E-7AB1-429D-9111-1708C0574994Q36795473-49397E04-1272-4735-AF04-2F65FEC2EB5DQ36955257-0D21B8BC-5195-4781-B030-E3A86074274FQ37008611-537B4943-171F-458E-BE1E-BA8BE9BAA109Q37117352-AA871DA4-1C03-4F6B-838C-337D0A69124BQ37133983-E2AF57D5-0D7B-43B5-A4EF-4FA468E8C915Q37154392-AA808010-DE04-40BB-B8D3-3AA50A0C7CD7
P2860
Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Beyond chloroquine: implicatio ...... nd treatment policy in Africa.
@en
type
label
Beyond chloroquine: implicatio ...... nd treatment policy in Africa.
@en
prefLabel
Beyond chloroquine: implicatio ...... nd treatment policy in Africa.
@en
P2093
P356
P1476
Beyond chloroquine: implicatio ...... nd treatment policy in Africa.
@en
P2093
Bloland PB
Campbell CC
Kazembe PN
Lackritz EM
Steketee R
P304
P356
10.1093/INFDIS/167.4.932
P407
P577
1993-04-01T00:00:00Z